Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00578851 · ClinicalTrials.gov registry record
A Clinical Investigation of the C2a-Taper™ Acetabular System
A clinical trial, sponsored by Biomet Orthopedics.
- Completed
- Registry status
- 28
- Enrollment target
NCT00578851 is a clinical trial that has completed, run by Biomet Orthopedics. The registered enrollment target is 28 participants.
The verdict
NCT00578851 has completed, sponsored by Biomet Orthopedics.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The objective of this study is to gather clinical and survivorship information for the C2a-Taper™ Acetabular System, a ceramic-on-ceramic hip articulating system.
Interventions
- DEVICE C2a - Taper™ Acetabular System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2006-04 |
| Est. Completion | 2015-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00578851
The ClinicalTrials.gov registry entry for NCT00578851 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biomet Orthopedics, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which C2a - Taper™ Acetabular System is the first listed.
NCT00578851 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00578851 about?
NCT00578851 is a clinical study titled "A Clinical Investigation of the C2a-Taper™ Acetabular System". The objective of this study is to gather clinical and survivorship information for the C2a-Taper™ Acetabular System, a ceramic-on-ceramic hip articulating system.
What is the current status of trial NCT00578851?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2006-04. Estimated completion is 2015-10.
What interventions are being tested in trial NCT00578851?
The interventions under investigation include: C2a - Taper™ Acetabular System (DEVICE).
Who is sponsoring clinical trial NCT00578851?
This trial is sponsored by Biomet Orthopedics, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.